Intraductal papillary mucinous neoplasms of the pancreas: a clinical challenge

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Introduction: The incidental detection rate of intraductal papillary mucinous neoplasms (IPMNs) has significantly increased. However, little is known about the natural history of these tumors. Their optimal management and appropriate follow-up are still unclear. We have, therefore, reviewed the available literature on IPMN focusing on their diagnosis, treatment according to the risk of malignant transformation, and follow-up. Areas covered: Bibliographical searches were performed in PubMed for the terms ‘intraductal papillary mucinous neoplasm’ and ‘natural history’ and ‘diagnosis’ and ‘treatment’ and ‘surgery’ and ‘follow-up’ and ‘prognosis.’ PubMed was used to search for all the relevant articles published over the last 10 years. A total of 7244 records were identified. After filtering for year range, English language, human studies, article types, and removing duplicates, 74 articles were left with the strongest level of evidence. Expert commentary: Available guidelines for IPMN management are mainly based on expert opinions and may lack strong evidence. Further studies are warranted to better predict the risk of recurrence/future malignancy and to establish standardized guidelines. IPMNs management should be based on multidisciplinary discussion and treatment should be tailored to an individual patient according to patient and tumor characteristics.

Original languageEnglish
Pages (from-to)1123-1133
Number of pages11
JournalExpert Review of Gastroenterology and Hepatology
Volume12
Issue number11
DOIs
Publication statusPublished - Nov 2 2018

Fingerprint

Pancreatic Neoplasms
Neoplasms
PubMed
Guidelines
Expert Testimony
Natural History
Language
Therapeutics
Recurrence

Keywords

  • diagnosis
  • follow-up
  • Intraductal papillary mucinous neoplasm
  • natural history
  • prognosis
  • surgery
  • treatment

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Intraductal papillary mucinous neoplasms of the pancreas : a clinical challenge. / Rossi, Roberta Elisa; Massironi, Sara.

In: Expert Review of Gastroenterology and Hepatology, Vol. 12, No. 11, 02.11.2018, p. 1123-1133.

Research output: Contribution to journalReview article

@article{ece0f8242110413b8bb334404c480b2c,
title = "Intraductal papillary mucinous neoplasms of the pancreas: a clinical challenge",
abstract = "Introduction: The incidental detection rate of intraductal papillary mucinous neoplasms (IPMNs) has significantly increased. However, little is known about the natural history of these tumors. Their optimal management and appropriate follow-up are still unclear. We have, therefore, reviewed the available literature on IPMN focusing on their diagnosis, treatment according to the risk of malignant transformation, and follow-up. Areas covered: Bibliographical searches were performed in PubMed for the terms ‘intraductal papillary mucinous neoplasm’ and ‘natural history’ and ‘diagnosis’ and ‘treatment’ and ‘surgery’ and ‘follow-up’ and ‘prognosis.’ PubMed was used to search for all the relevant articles published over the last 10 years. A total of 7244 records were identified. After filtering for year range, English language, human studies, article types, and removing duplicates, 74 articles were left with the strongest level of evidence. Expert commentary: Available guidelines for IPMN management are mainly based on expert opinions and may lack strong evidence. Further studies are warranted to better predict the risk of recurrence/future malignancy and to establish standardized guidelines. IPMNs management should be based on multidisciplinary discussion and treatment should be tailored to an individual patient according to patient and tumor characteristics.",
keywords = "diagnosis, follow-up, Intraductal papillary mucinous neoplasm, natural history, prognosis, surgery, treatment",
author = "Rossi, {Roberta Elisa} and Sara Massironi",
year = "2018",
month = "11",
day = "2",
doi = "10.1080/17474124.2018.1530111",
language = "English",
volume = "12",
pages = "1123--1133",
journal = "Expert Review of Gastroenterology and Hepatology",
issn = "1747-4124",
publisher = "Expert Reviews Ltd.",
number = "11",

}

TY - JOUR

T1 - Intraductal papillary mucinous neoplasms of the pancreas

T2 - a clinical challenge

AU - Rossi, Roberta Elisa

AU - Massironi, Sara

PY - 2018/11/2

Y1 - 2018/11/2

N2 - Introduction: The incidental detection rate of intraductal papillary mucinous neoplasms (IPMNs) has significantly increased. However, little is known about the natural history of these tumors. Their optimal management and appropriate follow-up are still unclear. We have, therefore, reviewed the available literature on IPMN focusing on their diagnosis, treatment according to the risk of malignant transformation, and follow-up. Areas covered: Bibliographical searches were performed in PubMed for the terms ‘intraductal papillary mucinous neoplasm’ and ‘natural history’ and ‘diagnosis’ and ‘treatment’ and ‘surgery’ and ‘follow-up’ and ‘prognosis.’ PubMed was used to search for all the relevant articles published over the last 10 years. A total of 7244 records were identified. After filtering for year range, English language, human studies, article types, and removing duplicates, 74 articles were left with the strongest level of evidence. Expert commentary: Available guidelines for IPMN management are mainly based on expert opinions and may lack strong evidence. Further studies are warranted to better predict the risk of recurrence/future malignancy and to establish standardized guidelines. IPMNs management should be based on multidisciplinary discussion and treatment should be tailored to an individual patient according to patient and tumor characteristics.

AB - Introduction: The incidental detection rate of intraductal papillary mucinous neoplasms (IPMNs) has significantly increased. However, little is known about the natural history of these tumors. Their optimal management and appropriate follow-up are still unclear. We have, therefore, reviewed the available literature on IPMN focusing on their diagnosis, treatment according to the risk of malignant transformation, and follow-up. Areas covered: Bibliographical searches were performed in PubMed for the terms ‘intraductal papillary mucinous neoplasm’ and ‘natural history’ and ‘diagnosis’ and ‘treatment’ and ‘surgery’ and ‘follow-up’ and ‘prognosis.’ PubMed was used to search for all the relevant articles published over the last 10 years. A total of 7244 records were identified. After filtering for year range, English language, human studies, article types, and removing duplicates, 74 articles were left with the strongest level of evidence. Expert commentary: Available guidelines for IPMN management are mainly based on expert opinions and may lack strong evidence. Further studies are warranted to better predict the risk of recurrence/future malignancy and to establish standardized guidelines. IPMNs management should be based on multidisciplinary discussion and treatment should be tailored to an individual patient according to patient and tumor characteristics.

KW - diagnosis

KW - follow-up

KW - Intraductal papillary mucinous neoplasm

KW - natural history

KW - prognosis

KW - surgery

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85055211681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055211681&partnerID=8YFLogxK

U2 - 10.1080/17474124.2018.1530111

DO - 10.1080/17474124.2018.1530111

M3 - Review article

AN - SCOPUS:85055211681

VL - 12

SP - 1123

EP - 1133

JO - Expert Review of Gastroenterology and Hepatology

JF - Expert Review of Gastroenterology and Hepatology

SN - 1747-4124

IS - 11

ER -